about
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.Engineering of in vitro 3D capillary beds by self-directed angiogenic sproutingA protein interaction map for cell-cell adhesion regulators identifies DUSP23 as a novel phosphatase for β-catenin.Synergistic effects of 3D ECM and chemogradients on neurite outgrowth and guidance: a simple modeling and microfluidic frameworkRegistered report: Discovery and preclinical validation of drug indications using compendia of public gene expression dataEnsemble analysis of angiogenic growth in three-dimensional microfluidic cell culturesControlled Drug Release and Chemotherapy Response in a Novel Acoustofluidic 3D Tumor Platform.Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function.Controlled electromechanical cell stimulation on-a-chip.Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogelsA novel microfluidic platform for high-resolution imaging of a three-dimensional cell culture under a controlled hypoxic environmentSpectrally resolved multidepth fluorescence imagingBiomimetic tissue-engineered systems for advancing cancer research: NCI Strategic Workshop reportIn vitro model of tumor cell extravasation.Microfluidic devices for studying heterotypic cell-cell interactions and tissue specimen cultures under controlled microenvironments.Transport-mediated angiogenesis in 3D epithelial cocultureNeutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.A microfluidic platform for studying the effects of small temperature gradients in an incubator environment.Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response.A high-throughput microfluidic assay to study neurite response to growth factor gradients.Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.Microfluidic platforms for studies of angiogenesis, cell migration, and cell-cell interactions. Sixth International Bio-Fluid Mechanics Symposium and Workshop March 28-30, 2008 Pasadena, California.Endothelial monolayer permeability under controlled oxygen tension.A novel, view-independent method for strain mapping in myocardial elastography: eliminating angle and centroid dependence.Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.BRAF and AXL oncogenes drive RIPK3 expression loss in cancerSurface-treatment-induced three-dimensional capillary morphogenesis in a microfluidic platformMicrofluidics: surface-treatment-induced three-dimensional capillary morphogenesis in a microfluidic platform (adv. Mater. 47/2009)Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of ResponsivenessA large peptidome dataset improves HLA class I epitope prediction across most of the human populationTuning Nanoparticle Interactions with Ovarian Cancer through Layer-by-Layer Modification of Surface ChemistryPooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer
P50
Q27333756-A59FD84F-2E6F-4C2D-8DFE-EDEADD2A85A7Q27333782-9A41F821-5A67-4D57-AE21-0706429A5502Q27348104-F9ACB66A-C37B-4F0D-947B-495128588446Q28539568-21D4038F-A2E8-40E5-894D-46910CE8662FQ28647069-867FC8F2-45DA-4768-8DE7-45CEAC6DC7A4Q28729177-E550C001-FBB0-4371-AFB4-9DC3F751A8F1Q30357837-AC2D6D7A-7E45-4A53-A73A-C13DF56731EBQ30524355-0B19181B-6F5A-4226-82DB-9C8A60273F5BQ30656306-5C65F496-A6DF-41C7-B8D4-726E2FC21571Q33669086-02836776-D838-4F03-A11B-44C8611D3C32Q33861537-46ACF459-3A9F-43F3-80B2-8FA488DD88A7Q34032400-68CE6E89-B7D0-4E2B-8B7E-FD31FC498C7FQ34287947-421D59CF-A25D-4E80-A823-788F26A5A009Q34599684-7FD397B6-AC7C-448A-B974-4EDB629C7C1BQ34856569-0981FD4E-ADE5-427A-9C6F-A5BF3C8F0D94Q34952930-F92A0328-F5DB-4EC3-8DFD-70E1CD6777D2Q37031596-B0AF508D-76AF-4948-870D-28CCABD5801BQ37278338-FAE89519-CF91-45AE-A415-0662E1F05EF8Q38605020-7324D788-DAB8-4914-ABA1-BE1C2F993427Q39627652-13D59179-1C73-4DEA-808D-51FD06F55F18Q41674789-64B9676D-8A65-472E-90C1-5263847CB066Q43411528-E4B992A1-2539-46E7-B4EA-4B016A7E4043Q50881751-6FA8DF70-A453-4DAF-876B-059F287B8AD0Q50947880-ABFC2610-FA88-4DA9-8B58-4A53FD890786Q52851743-CEB57B1C-1E75-4B42-B40C-78DF75DFC77CQ58696646-F66B9FC8-FAB6-4B44-BD75-111B92611249Q82303294-2E7B0F7C-22C2-4005-8AC4-25CF2526460DQ82326134-46A615C0-5B96-44C0-87C3-A8A88AB4B43BQ91210538-82943655-3FDF-4E36-AD35-0F953674ADD6Q92025822-A38E1B49-3FA2-4F2C-8556-B053DF7E7D8DQ92873678-FCB85019-0318-41C4-9E6F-017A3627E257Q92964265-A3C7E839-29E1-4108-99C9-653A6DFECD65
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ioannis K Zervantonakis
@ast
Ioannis K Zervantonakis
@en
Ioannis K Zervantonakis
@es
Ioannis K Zervantonakis
@nl
Ioannis K Zervantonakis
@sl
type
label
Ioannis K Zervantonakis
@ast
Ioannis K Zervantonakis
@en
Ioannis K Zervantonakis
@es
Ioannis K Zervantonakis
@nl
Ioannis K Zervantonakis
@sl
prefLabel
Ioannis K Zervantonakis
@ast
Ioannis K Zervantonakis
@en
Ioannis K Zervantonakis
@es
Ioannis K Zervantonakis
@nl
Ioannis K Zervantonakis
@sl
P1053
C-2890-2011
P106
P21
P2798
P31
P3829
P496
0000-0003-2386-9553